Literature DB >> 23763968

Use of the intrauterine device among adolescent and young adult women in the United States from 2002 to 2010.

Amy K Whitaker1, Katherine M Sisco, Ashley N Tomlinson, Annie M Dude, Summer L Martins.   

Abstract

PURPOSE: Long-acting contraceptives, such as the intrauterine device (IUD), show potential for decreasing the incidence of unintended pregnancy. However, use among adolescent and young adult women remains low. We determined factors associated with IUD use among young women.
METHODS: We conducted an analysis of nationally representative, cross-sectional data from the 2002 and 2006-2010 National Surveys of Family Growth. We included sexually active women 15-24 years old. We used bivariate analysis to compare proportions of ever-use of any type of IUD in 2002 and in 2006-2010 and multivariable logistic regression to identify correlates of ever-use in 2006-2010.
RESULTS: We found an increase in IUD use in teens 15-19 years old, from .2% to 2.5% (p < .001), and among women 20-24 years old, 2.0% to 5.4% (p < .001). Use increased among nearly all subgroups of respondents. Compared with nulliparous young women, those with one prior delivery and with two or more deliveries were substantially more likely to have used an IUD (adjusted OR 11.43, 95% CI 3.61-36.16, and adjusted OR 13.60, 95% CI 4-46.48, respectively). Young black women were less likely to report IUD use (adjusted OR .32, 95% CI .16-.66), and women whose mothers received at least a high school education were more likely to report use (adjusted OR 2.56, 95% CI 1.22-5.43).
CONCLUSIONS: IUD use is increasing among adolescent and young adult women overall and among almost all sociodemographic subgroups. Nonetheless, use remains low, and nulliparous young women are highly unlikely to use the IUD.
Copyright © 2013 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent; Contraception; Contraceptive use; IUD (intrauterine device); NSFG (National Survey of Family Growth)

Mesh:

Year:  2013        PMID: 23763968     DOI: 10.1016/j.jadohealth.2013.04.011

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  7 in total

1.  "I don't know enough to feel comfortable using them:" Women's knowledge of and perceived barriers to long-acting reversible contraceptives on a college campus.

Authors:  Kelli Stidham Hall; Elizabeth Ela; Melissa K Zochowski; Amy Caldwell; Michelle Moniz; Laura McAndrew; Monique Steel; Sneha Challa; Vanessa K Dalton; Susan Ernst
Journal:  Contraception       Date:  2016-02-13       Impact factor: 3.375

2.  Complications and continuation rates associated with 2 types of long-acting contraception.

Authors:  Abbey B Berenson; Alai Tan; Jacqueline M Hirth
Journal:  Am J Obstet Gynecol       Date:  2014-12-30       Impact factor: 8.661

3.  Economic Burden of Contraception Management in Spain.

Authors:  Inmaculada Parra Ribes; Juan José Rascón Poza; Ezequiel Pérez Campos; Ignacio Bugella Yudice; Maria Jesús Rodríguez Domingo
Journal:  J Health Econ Outcomes Res       Date:  2018-04-16

4.  Changes in Diverse Sexual and Contraceptive Behaviors Across College.

Authors:  Eva S Lefkowitz; Sara A Vasilenko; Rose Wesche; Jennifer L Maggs
Journal:  J Sex Res       Date:  2018-08-02

5.  Sporadic contraceptive use and nonuse: age-specific prevalence and associated factors.

Authors:  Karen Pazol; Maura K Whiteman; Suzanne G Folger; Athena P Kourtis; Polly A Marchbanks; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2014-10-08       Impact factor: 8.661

6.  Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion.

Authors:  Brandon Howard; ElizaBeth Grubb; Maureen J Lage; Boxiong Tang
Journal:  Reprod Health       Date:  2017-06-08       Impact factor: 3.223

Review 7.  Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States.

Authors:  Jennie Yoost
Journal:  Patient Prefer Adherence       Date:  2014-07-03       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.